[Metronidazole-spiramycin combination. In situ concentrations and synergism compared with the minimal inhibitory concentration of the buccal flora].
D000539:Alveolar Process / Q000032:analysis; D001711:Biotransformation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005881:Gingiva / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D007239:Infections / Q000188:drug therapy; D007933:Leucomycins / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D008795:Metronidazole / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D009059:Mouth Diseases / Q000188:drug therapy*; D012463:Saliva / Q000032:analysis; D013223:Statistics as Topic
D007933:Leucomycins; D008795:Metronidazole
L'association métronidazole-spiramycine. Concentrations et synergie in situ comparées aux CMI de la flore buccale.